Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
16.96
-0.24 (-1.40%)
Jun 8, 2026, 4:00 PM EDT - Market closed
Ascentage Pharma Group International Employees
Ascentage Pharma Group International had 767 employees as of December 31, 2025. The number of employees increased by 200 or 35.27% compared to the previous year.
Employees
767
Change
200
Growth
35.27%
Revenue / Employee
$107,018
Profits / Employee
-$231,657
Market Cap
1.59B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 767 | 200 | 35.27% |
| Jun 30, 2025 | 605 | - | - |
| Dec 31, 2024 | 567 | -16 | -2.74% |
| Dec 31, 2023 | 583 | 3 | 0.52% |
| Dec 31, 2022 | 580 | -33 | -5.38% |
| Dec 31, 2021 | 613 | 180 | 41.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Sarepta Therapeutics | 835 |
| AbCellera Biologics | 562 |
| Agios Pharmaceuticals | 540 |
| Nurix Therapeutics | 317 |
| Capricor Therapeutics | 231 |
| Innoviva | 159 |
| Taysha Gene Therapies | 99 |
AAPG News
- 7 days ago - Ascentage Pharma presents data on olverembatinib - TheFly
- 7 days ago - Ascentage Pharma presents data from Phase 1b study of olverembatinib - TheFly
- 7 days ago - Ascentage Pharma presents first dataset of alrizomadlin - TheFly
- 7 days ago - Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026 - GlobeNewsWire
- 7 days ago - Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026 - GlobeNewsWire
- 7 days ago - Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026 - GlobeNewsWire
- 17 days ago - Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026 - GlobeNewsWire
- 26 days ago - Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress - GlobeNewsWire